Interference 102,760
FINAL DECISION
1. Background
February 12, 1990 -- Jeffrey L. Schwimmer (hereafter
Schwimmer) filed Application 07/478,820. Original Claim 1
thereof reads in pertinent part:
1. A method for treatment of sleep apneas
comprising
administration of a therapeutically effective regimen of
a Formula I azapirone compound or a pharmaceutically[1]
effective acid addition salt thereof to a patient in need
of such treatment . . . .
February 12, 1990 -- William C. Dement (hereafter
Dement), Mark R. Rosekind (hereafter Rosekind), and Schwimmer
filed Application 07/479,803. Original Claim 1 thereof reads
in pertinent part:
1. A method for treatment of sleep apneas
comprising
administration of a therapeutically effective regimen of
buspirone or a pharmaceutically effective acid addition
salt thereof to a patient in need of such treatment.
February 14, 1990 -- David M. Rapoport (hereafter
Rapoport) filed Application 07/479,693. Original Claim 1
thereof reads in pertinent part:
1 Although buspirone is an azapirone compound, the
azapirone compounds of Schwimmer’s Formula I appear to exclude
buspirone.
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007